WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

Feb 20, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-02-18

Reporting Person: MILLER GEORGE LLOYD (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-18	Common Stock	A	2052.00	$173.22	Acquired	8620.6517	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-18	Stock Options (Right to Buy)	$173.22	A	7652.00	Acquired	2030-02-18	Common Stock (7652.00)	Direct

Footnotes

F1: 2017 PSUs (PP16) award vesting.

F2: Balance on form 4 that was filed on November 22, 2019 was incorrectly reported due to the share withholding amount changing.

F3: This award vests in four equal annual installments beginning on February 18, 2021.